Abstract:Purpose: In a previous study, we found that transforming growth factor beta-induced (TGFBI) is a hub gene strongly associated with oral squamous cell carcinoma (OSCC), using gene chip meta-analysis and PPI network analysis. Thus, the present study was established to explore the role of TGFBI in the pathogenesis of OSCC and to define the underlying mechanisms. Methods: The correlations between TGFBI expression and the clinicopathological features and prognosis of OSCC were analyzed. Then, TGFBI-knockout HSC-3 cell lines were constructed using the CRISPR/Cas9 system. Cell proliferation, migration, and invasion in vitro were determined by cell counting, CCK-8, colony formation, and Transwell assays. Moreover, a xenograft animal study was implemented to determine the tumorigenicity and metastatic ability associated with TGFBI in vivo. The genes and pathways differentially expressed after TGFBI knockout were determined using transcriptional sequencing and bioinformatics. Results: TGFBI expression was significantly higher in OSCC than in normal tissue. Its high expression was also correlated with high stage and was predictive of poor prognosis, as we expected. Knockout of TGFBI inhibited cell proliferation and clone formation, and enhanced cell migration and invasion in vitro. Besides, the xenograft animal study showed that TGFBI knockout suppressed tumor growth and metastasis in vivo. Furthermore, transcriptome sequencing revealed that genes associated with cell proliferation, metastasis, and inflammatory responses exhibited a change of expression upon TGFBI knockout. GO and KEGG analyses indicated that the function of TGFBI is related to responses to bacteria and inflammatory responses. Conclusions: TGFBI overexpression can promote OSCC and is associated with poor prognosis in OSCC patients. TGFBI knockout can inhibit cell proliferation and metastasis in vivo. TGFBI may alter cell responses to bacteria, which causes an imbalance in the immune inflammatory response and promotes the development of OSCC.

Epigenetic Regulation of Integrin Β6 Transcription Induced by TGF‐β1 in Human Oral Squamous Cell Carcinoma Cells

Lysophosphatidic Acid Induces Integrin Β6 Expression in Human Oral Squamous Cell Carcinomas Cells Via LPAR1 Coupling to Gαi and Downstream SMAD3 and ETS-1 Activation

Site-directed analysis of key transcriptionaI regulatory regions of ITGB6 gene in oral squamous cell carcinoma cells

Cloning and Characterization of the Human Integrin β6 Gene Promoter

Transgenic Overexpression of ITGB6 in Intestinal Epithelial Cells Exacerbates Dextran Sulfate Sodium‐induced Colitis in Mice

Transforming Growth Factor-Β1 and Lysophosphatidic Acid Activate Integrin Β6 Gene Promoter in Hep-3B Cells.

C1QTNF6 Promotes Oral Squamous Cell Carcinoma by Enhancing Proliferation and Inhibiting Apoptosis

The expression and clinical relevance of integrinαvβ6 and JunB in oral squamous cell carcinoma

Upregulation of LY6K induced by FTO-mediated demethylation promotes the tumorigenesis and metastasis of oral squamous cell carcinoma via CAV-1-mediated ERK1/2 signaling activation

The Secretion of IL-6 by CpG-ODN-treated Cancer Cells Promotes T-cell Immune Responses Partly Through the TLR-9/AP-1 Pathway in Oral Squamous Cell Carcinoma

A comprehensive investigation regarding the clinical significance of ITGB4 in oral squamous cell carcinoma combining immunohistochemistry, RNA-seq, and microarray data

Cytoplasmic eIF6 promotes OSCC malignant behavior through AKT pathway

HoxC6 Functions As an Oncogene and Isoform HoxC6-2 May Play the Primary Role in Gastric Carcinogenesis

TGFBI Promotes Tumor Growth and is Associated with Poor Prognosis in Oral Squamous Cell Carcinoma

ITGB6 inhibition stimulates anti-tumor responses in immunocompetent mouse models of head & neck squamous cell carcinoma and pancreatic adenocarcinoma

Super-enhancer-driven ITGA6 enhances stemness features of squamous cell carcinoma through stabilizing c-myc protein

Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/STAT3/Sox4/NLRP3 signaling pathway

CRISPR/Cas9-mediated knock out of ITGB6 in human OSCC cells reduced migration and proliferation ability

A novel oncogene trigger transposable element derived‐1 promotes oral squamous cell carcinoma progression via evoking immune inhibition

ITGB6 promotes pancreatic fibrosis and aggravates the malignant process of pancreatic cancer via JAK2/STAT3 signaling pathway

Knockdown of Myosin 6 Inhibits Proliferation of Oral Squamous Cell Carcinoma Cells